Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.
Carfilzomib falls under the class of medications known as proteasome inhibitors. It works in order to inhibit or resist the growth of cancer cells in a patient's body.
Carfilzomib is a prescription drug introduced for the treatment of adult patients with relapsed/refractory MM who have received one to three previous treatments for multiple myeloma. The cost of carfilzomib may vary from around Rs. 9990 to Rs. 47325 for a supply of a vial of 1 injection.